Swah: Trust to consult on ending hospital surgery services
Campaigners say the loss of services and the distance and travel time, as well as poor transport infrastructure, put lives at risk.Neil Guckian, the chief executive of the Western Trust, told the board meeting that it was "not a rushed decision" and he understood the "strength of feeling" that this issue generates."We have over two and a half years of working under these pathways. Working effectively with no concerns on patient safety," he added. Mr Guckian said evidence showed that patients who need to go to Altnagelvin Hospital "have better clinical outcomes" and "no patient has come to harm".
'No clinically adverse outcomes for patients'
Dr Brendan Lavery, medical director of the Western Trust, said that independent evidence showed there was a "very significant difference in mortality scores" between the Swah and Altnagelvin hospitals."When comparing the two units Altnagelvin comes out considerably better," he added.He told the meeting that during the temporary suspension of surgical services there were "no clinically adverse outcomes for patients".Mark Gillespie, director of surgery, paediatrics and women's health at the Western Trust, said the temporary suspension of general surgery had "transformed and improved patient outcomes"."The proposal has the support of the surgical consultant workforce and myself as director."Geraldine McKay, director of unscheduled care, medicine, cancer and clinical services at the Western Trust, outlined the intention to launch the 12-week consultation on 8 July on the Western Trust website.The Western Trust also plans to hold a series of "consultation events" including in Fermanagh, Londonderry and virtually.The consultation responses will be published in the winter of 2026 with ministerial approval needed for any enactment of change.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
BBC News
10 hours ago
- BBC News
More weight-loss drugs offered in type 2 diabetes care shake-up
Treatment for millions of people with type 2 diabetes should be more personalised, with greater access to newer medicines, including weight-loss drugs, the healthcare assessment body for England, Wales and Northern Ireland has calls the move "the biggest shake-up" in type 2 diabetes care in a more people the new drugs will prevent complications such as heart disease, strokes and kidney damage, reduce costs to the NHS and potentially save lives, the National Institute for Health and Care Excellence (NICE) says. Around 4.6 million people in the UK are diagnosed with diabetes - of these 90% have type 2, with another 1.3 million likely to be undiagnosed. Having type 2 diabetes means there is too much glucose or sugar in the blood. This makes strokes, heart attacks, heart failure and other health conditions much more of a risk. It is now so common that 10% of the NHS budget goes towards treating which produces guidance for the NHS on how to give patients the best care, recommends a move away from a "one size fits all" approach and towards more personalised is calling for newer diabetes medicines called SGLT-2 inhibitors, which protect the heart and kidneys as well as lowering blood sugar levels, to become the first-choice treatment for all diabetes patients. Around 2.3 million people will be eligible for these 22,000 lives could be saved if 90% of all diabetes patients were prescribed them, NICE says, but access is not equal across the UK. There is evidence that women, older people and black people are less likely to be prescribed them."There is some urgency to find ways to increase the uptake of SGLT-2 inhibitors because if we were to achieve perfect uptake, the nation would be significantly healthier," said Dr Waqaar Shah, chair of the guideline one in five people with type 2 diabetes and cardiovascular disease are currently prescribed the the tablets to more people would particularly benefit those living in poorer areas and ethnic minorities, NICE says. Under the guidance, which is still at a draft stage and needs to go through a consultation, around 750,000 more people with type 2 diabetes will be offered GLP-1 agonists such as semaglutide and liraglutide, which have become very popular as the drugs contained in weight-loss with cardiovascular disease and some who develop type 2 before they are 40 are the groups recommended to be offered drugs can be used both to lower blood sugar levels and to support some people with weight Jonathan Benger, deputy chief executive and chief medical officer at NICE, said the updated guidance was "a significant evolution" in type 2 diabetes treatment which could help prevent heart attacks, strokes and other serious complications before they happen."This guidance means more people will be offered medicines, where it is right to do so, to reduce their future risk of ill health," he guidelines are part of a long-term plan by the NHS in England to reduce health inequalities and focus on preventing ill health in the first charity Diabetes UK said the announcement propelled type 2 diabetes treatments "into the 21st century"."These guidelines could go a long way to easing the burden of living with this relentless condition, as well as helping to address inequities in type 2 diabetes treatments and outcomes," said Douglas Twenefour, head of clinical at the charity.
BBC News
12 hours ago
- BBC News
Myopia: Children in NI treated different to those in the rest of the UK
Children with short-sightedness are being stopped from using NHS vouchers to help pay for new treatment unlike in other parts of the UK, Northern Ireland optometrists have chair of Optometry NI, Brian McKeown, said it was "frustrating" and that the rules should change, while Faith Donaldson, a County Down-based optometrist, said advances in medicine can now "slow down the progressions of myopia".However, the Department of Health said the "evidence is not yet sufficient to support funded use".Myopia, which is the medical term for short-sightedness, is an extremely common eye condition that affects about one in three people in the UK. Children can use NHS vouchers, worth between £40 and £60, towards the cost of glasses to help them see more clearly but cannot use them for special glasses or contact lenses that help to treat the treatment - known as myopia management - can slow or stop the short-sightedness from getting Donaldson said she feels obligated to tell families about myopia management and that the College of Optometrists has said it is "best practise and we should be advising and telling our patients about it". Danny, 13, wears contact lenses that treat myopia and has seen for himself the difference they can make. He said he noticed his vision getting worse while wearing glasses, which was confirmed by eye starting myopia management slowed down that progression. "My next eye test after I got my contacts the first time, you noticed there was quite a big stop or little to no difference." Danny's sister is also short-sighted. Their mum Emma McManus said it was a "no-brainer" to pay privately for both of them to have myopia said they would do whatever they could to "slow that (myopia) down, save their eyesight". It costs about £30 a month for Danny's contacts and about £300 in total for her daughter's glasses, which treat the McManus knew that she could not use the NHS voucher towards myopia management but was not aware it could be used in other parts of the feels that puts families here at a disadvantage."That could make the difference between another household opting into the myopia management or having to say: 'No I just can't do that.'"I think that is just so unfair." Brian McKeown, the chair of Optometry NI which represents all optometrists in Northern Ireland, said the "evidence is definitely growing" for myopia said he has patients in his own practice who have seen the benefit and that it was "frustrating" that people in the rest of the UK can use vouchers towards the treatment."We feel there should be a change," he McKeown said a paper has been submitted to the body that makes decisions on funding matters like these and they are waiting for an official response. The Department of Health said it "continues to monitor the situation, and examine the available evidence, but to date the position remains unchanged".It said officials have met with Optometry NI and assured "the profession that the Department of Health continues to take an interest in the subject". What are the signs of short-sightedness? Difficulty reading words from a distance, such as reading the whiteboard at school Sitting close to the TV or computer, or holding a mobile phone or tablet close to the face Getting headaches Rubbing the eyes a lot
BBC News
a day ago
- BBC News
Darlington hospital fall patient had care plan reduced
A man who died after an accidental hospital fall had his care visits reduced in error in the days before his death, a coroner has Hutchens, who was a patient at Darlington Memorial Hospital, died on 27 85-year-old had his care rounds reduced from hourly to four-hourly in the week before his death, a prevention of future deaths report Sutton, assistant coroner for County Durham and Darlington, has sent a formal warning to the hospital trust over concern the error could occur again. The BBC has approached County Durham and Darlington NHS Foundation Trust for comment. Mr Hutchens died due to a head injury caused by an accidental fall at the hospital, an inquest 20 February, seven days before his death, a member of staff mistakenly downgraded his care visits to every four hours, but Ms Sutton said they were unaware of how the error occurred. "It cannot be said, on a balance of probabilities, that the error contributed to the deceased's death," her report she admitted there was a "concern that the error could occur again and could cause or contribute to a future death".The report, sent to the trust's chief executive, must have a legal response from the trust by 2 October. Follow BBC North East on X, Facebook, Nextdoor and Instagram.
